Dyne Therapeutics DYN SEC Filings

NASDAQ DYN
$24.45 -0.50 (-2.00%)
As of: Sep 4, 2026 · 11:50 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Dyne Therapeutics, Inc. (DYN) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index